Gerry Hanna

Gerry Hanna Highlights a Study on Tumor Control and Immune Activation with Palliative Irradiation and ATR Inhibition

Gerry Hanna, Marie Curie Chair of Clinical Oncology at Trinity College Dublin, posted on X about recent paper by Magnus T. Dillon et al., published in Nature Communications.

“Thanks to Hegi Fiona for flagging Peter Mac Radiation Oncology fellow Magnus Dillon’s paper on the PATRIOT study led by The ICR’s Kevin Harrington.

Superb science and highly encouraging responses

Of note High T and NK cell activation in peripheral blood.”

Title: Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trial

Authors: Magnus T. Dillon, Emmanuel C. Patin, Kabir Mohammed, Jeane Guevara, Simon A. Smith, Emma Dean, Heba Soliman, Pablo Nenclares, Motoko Ryugenji, Davina Northcote, Neel Shah, Lorna Grove, Christopher J. Lord, Stephen Pettit, Matt Tall, Karen E. Swales, Udai Banerji, Alan A. Melcher, Mark Saunders, Martin D. Forster, Kevin J. Harrington

Read The Full Article.

Gerry Hanna Highlights a Study on Tumor Control and Immune Activation with Palliative Irradiation and ATR Inhibition

More posts featuring Gerry Hanna on OncoDaily.